Literature DB >> 3229902

Evaluation of daunomycin toxicity on lens epithelium in vitro.

M Weller1, P Wiedemann, R Fischbach, C Hartmann, K Heimann.   

Abstract

Posterior capsule opacification is the major complication of extracapsular cataract extraction (ECCE). Lens epithelial cells derived from the periphery of the lens are thought to migrate posteriorly and contribute significantly to the postoperative proliferations at the posterior pole. We have evaluated the effects of the antiproliferative drug daunomycin on cultured porcine lens epithelial cell viability and proliferation. We observed that the mitotic activity of the cells is suppressed by a single short time treatment with daunomycin at a concentration as low as 2.5 mg/l. Long term effects on the reproductive capacity of the lens epithelial cells may not be as pronounced as the inhibition of other cells examined before e.g. retinal pigment epithelium and fibroblasts. Our results indicate that daunomycin may be useful for the pharmacologic prevention of postoperative proliferations in patients treated by ECCE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3229902     DOI: 10.1007/bf00137138

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  11 in total

1.  The role of fibroblast growth factor and epidermal growth factorin the proliferative response of the corneal and lens epithelium.

Authors:  D Gospodarowicz; A L Mescher; K D Brown; C R Birdwell
Journal:  Exp Eye Res       Date:  1977-12       Impact factor: 3.467

2.  Identification of noncollagenous components of calf lens capsule: evaluation of their adhesion-promoting activity.

Authors:  P R Cammarata; R G Spiro
Journal:  J Cell Physiol       Date:  1985-12       Impact factor: 6.384

3.  Cytotoxic effects of daunomycin on retinal pigment epithelium in vitro.

Authors:  M Weller; K Heimann; P Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

4.  Posterior capsule opacification in pseudophakic eyes.

Authors:  P J McDonnell; M A Zarbin; W R Green
Journal:  Ophthalmology       Date:  1983-12       Impact factor: 12.079

5.  Pathogenesis of capsular opacification after extracapsular cataract extraction. An animal model.

Authors:  L M Cobo; E Ohsawa; D Chandler; R Arguello; G George
Journal:  Ophthalmology       Date:  1984-07       Impact factor: 12.079

6.  Lens epithelial cell adhesion to lens capsule: a model system for cell-basement membrane interaction.

Authors:  P R Cammarata; R G Spiro
Journal:  J Cell Physiol       Date:  1982-11       Impact factor: 6.384

7.  Human posterior subcapsular cataract. An ultrastructural study of the posteriorly migrating cells.

Authors:  J Eshaghian; B W Streeten
Journal:  Arch Ophthalmol       Date:  1980-01

8.  Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo.

Authors:  P Wiedemann; N Sorgente; C Bekhor; R Patterson; T Tran; S J Ryan
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-05       Impact factor: 4.799

9.  Intraocular daunorubicin for the treatment and prophylaxis of traumatic proliferative vitreoretinopathy.

Authors:  P Wiedemann; K Lemmen; R Schmiedl; K Heimann
Journal:  Am J Ophthalmol       Date:  1987-07-15       Impact factor: 5.258

10.  Cellular migration, proliferation, and contraction. An in vitro approach to a clinical problem--proliferative vitreoretinopathy.

Authors:  C Verdoorn; V W Renardel de Lavalette; J Dalma-Weizhausz; G M Orr; N Sorgente; S J Ryan
Journal:  Arch Ophthalmol       Date:  1986-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.